Skip Navigation


Carcinogenesis Advance Access originally published online on July 6, 2005
Carcinogenesis 2006 27(1):43-52; doi:10.1093/carcin/bgi174
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
27/1/43    most recent
bgi174v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Feng, G.
Right arrow Articles by Chang, P.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feng, G.
Right arrow Articles by Chang, P.-L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis vol.27 no.1 © Oxford University Press 2005; all rights reserved.

Production of chemokine CXCL1/KC by okadaic acid through the nuclear factor-{kappa}B pathway

Gong Feng 1, Yoshihiro Ohmori 3 and Pi-Ling Chang 1, 2, *

1 Department of Nutrition Sciences and 2 Comprehensive Cancer Center, University of Alabama at Birmingham, AL 35294-3360, USA and 3 Center for Molecular Biology, Meikai University School of Dentistry, Saitama 350-0283, Japan

* To whom correspondence should be addressed at: Department of Nutrition Sciences, 311 Susan Mott Webb Nutrition Sciences Building, 1675 University Boulevard, University of Alabama at Birmingham, Birmingham, AL 35295-3360. Tel: +1 205 975 6624; Fax: +1 205 934 7049; Email: plchang{at}uab.edu

The murine chemokine CXCL1/KC is known as a chemoattractant for neutrophil infiltration and as a promoter of tumor growth. To determine its relevance in tumorigenesis, we first asked whether okadaic acid (OKA), a natural tumor promoter and a potent protein phosphatase 1 and 2A inhibitor, stimulates KC expression and if it does, through what pathway, in a promotable mouse epidermal-like JB6 cell line commonly used for studying molecules related to tumor promotion. We found that OKA stimulated the de novo synthesis of KC mRNA and protein in a dose- and time-dependent manner. To determine the mechanism by which OKA stimulated the expression of KC at the transcriptional level, transient transfection assays using serially deleted sections of KC promoter fused to luciferase reporter gene were performed. These studies showed that transactivation of KC promoter by OKA specifically involved the region between –104 and –59 containing the two nuclear factor-kappaB (NF-{kappa}B) response elements ({kappa}B1 and {kappa}B2). Further analyses using the mutated NF-{kappa}B response elements {kappa}B1 and {kappa}B2 indicated that both regions were required for optimum transactivation of KC by OKA with the former NF-{kappa}B response element playing a more significant role in regulating KC expression. Gel-shift and supershift analyses demonstrated the involvement of three NF-{kappa}B subunits, p65, p50 and c-Rel, with p65 as the major subunit in the NF-{kappa}B dimer complex. Additionally, immunohistochemistry and western blot analyses confirmed the presence of p65 in the nucleus with its transactivation domain phosphorylated at serine 536. In summary, this is the first report to show that the tumor promoter OKA can stimulate the de novo synthesis and secretion of KC, and that this stimulation is mediated through the NF-{kappa}B pathway in JB6 cells.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CVIHome page
P. Mendez-Samperio, A. Trejo, and A. Perez
Mycobacterium bovis Bacillus Calmette-Guerin Induces CCL5 Secretion via the Toll-Like Receptor 2-NF-{kappa}B and -Jun N-Terminal Kinase Signaling Pathways
Clin. Vaccine Immunol., February 1, 2008; 15(2): 277 - 283.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. H. Boyd, M. Divangahi, L. Yahiaoui, D. Gvozdic, S. Qureshi, and B. J. Petrof
Toll-Like Receptors Differentially Regulate CC and CXC Chemokines in Skeletal Muscle via NF-{kappa}B and Calcineurin
Infect. Immun., December 1, 2006; 74(12): 6829 - 6838.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.